Markets › United States › NAS › PACB

Pacific Biosciences of California Inc

NAS:PACBHealthcareCBOEFTSE:MRUTNASDAQ:NBI

$1.90+3.26%LiveIn session · ≈ AED 6.98 · Market cap $590.58M · Next earnings Tue 3 Nov

Ratio	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025	Current · undated	YoY
Gross margin	41.3%	45.1%	38.2%	26.3%	24.2%	31.7%	—	—
Operating margin	−132.3%	−161.2%	−239.4%	−166.8%	−308.0%	−348.5%	−348.5%	+0.0 pts
Net margin	37.3%	−138.9%	−244.9%	−153.0%	−201.2%	−341.5%	−341.5%	+0.0 pts
EBITDA margin	49.4%	−192.1%	−220.0%	−135.2%	−157.6%	−21.4%	—	—
Return on equity	8.8%	−22.9%	−55.8%	−43.7%	−61.2%	−10,214.5%	−10,214.5%	+0.0 pts
Return on assets	7.1%	−9.0%	−17.8%	−17.6%	−24.6%	−69.7%	−69.7%	+0.0 pts
Return on capital employed	−27.8%	−10.9%	−20.4%	−20.3%	−39.7%	−76.4%	—	—
Debt / equity	0.1×	1.2×	1.7×	1.3×	1.3×	142.0×	142.0×	+0.0%
Debt / assets	10.1%	47.6%	53.7%	53.5%	53.3%	96.9%	—	—
Interest coverage	−391.0×	−16.8×	−20.9×	−23.3×	−35.4×	−80.2×	—	—
Current ratio	9.2×	15.4×	3.2×	7.8×	7.5×	6.9×	6.9×	+0.0%
Quick ratio	8.9×	15.0×	3.0×	7.2×	6.6×	6.0×	—	—
Cash ratio	2.1×	6.4×	1.2×	1.9×	0.8×	1.2×	1.2×	+0.0%
Asset turnover	0.2×	0.1×	0.1×	0.1×	0.1×	0.2×	—	—
Inventory turnover	3.3×	2.9×	1.6×	2.6×	2.0×	2.2×	—	—
Receivables turnover	4.7×	5.4×	6.8×	5.5×	5.6×	4.5×	—	—
Dividend payout	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	—	—